Quick Answer
CROSS COUNTRY HEALTHCARE INC reported Total Revenue of $1.05 billion for the year ending 2025.
- CROSS COUNTRY HEALTHCARE INC showed a decrease of -21.6% in Total Revenue from 2024 to 2025.
- This data is from CROSS COUNTRY HEALTHCARE INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2016 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $207.57 million | Q2 2017: $209.31 million | Q3 2017: $228.49 million | Q4 2017: $219.67 million | Q1 2018: $210.29 million | Q1 2018: $210.29 million | Q2 2018: $204.57 million | Q2 2018: $204.57 million | Q3 2018: $200.72 million | Q3 2018: $200.72 million | Q4 2018: $200.91 million | Q4 2018: $200.91 million | Q1 2019: $195.17 million | Q1 2019: $195.17 million | Q2 2019: $202.76 million | Q2 2019: $202.76 million | Q3 2019: $209.20 million | Q3 2019: $209.20 million | Q4 2019: $215.10 million | Q1 2020: $210.06 million | Q1 2020: $210.06 million | Q2 2020: $216.78 million | Q2 2020: $216.78 million | Q3 2020: $193.97 million | Q3 2020: $193.97 million | Q4 2020: $215.61 million | Q1 2021: $329.24 million | Q2 2021: $331.83 million | Q3 2021: $374.91 million | Q4 2021: $640.68 million | Q1 2022: $788.73 million | Q2 2022: $753.56 million | Q3 2022: $636.10 million | Q4 2022: $628.22 million | Q1 2023: $622.71 million | Q2 2023: $540.70 million | Q3 2023: $442.29 million | Q4 2023: $414.04 million | Q1 2024: $379.17 million | Q2 2024: $339.77 million | Q3 2024: $315.12 million | Q4 2024: $309.94 million | Q1 2025: $293.41 million | Q2 2025: $274.07 million | Q3 2025: $250.05 million | Q4 2025: $236.76 million.
- Over the full 12 years of available data (2016 to 2025), CROSS COUNTRY HEALTHCARE INC's Total Revenue has grown by 26.5%.
- Historical annual values: Fiscal year 2025: $1.05 billion | Fiscal year 2024: $1.34 billion | Fiscal year 2023: $2.02 billion | Fiscal year 2022: $2.80 billion | Fiscal year 2021: $1.68 billion | Fiscal year 2020: $836.42 million | Fiscal year 2019: $822.22 million | Fiscal year 2018: $816.48 million | Fiscal year 2018: $816.48 million | Fiscal year 2017: $865.05 million | Fiscal year 2017: $865.05 million | Fiscal year 2016: $833.54 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: